7 | Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2015
-
01/2000 |
6 | Vasopressins (Vasopressin)IBA
07/2014
-
11/2003 |
5 | DNA (Deoxyribonucleic Acid)IBA
03/2019
-
05/2004 |
4 | Therapeutic UsesIBA
10/2021
-
01/2012 |
4 | Topotecan (Hycamtin)FDA LinkGeneric
10/2021
-
01/2019 |
4 | tyrosyl-DNA phosphodiesteraseIBA
10/2021
-
01/2019 |
4 | Pharmaceutical PreparationsIBA
07/2017
-
01/2002 |
3 | usnic acidIBA
10/2021
-
01/2019 |
3 | Liposomes (Liposome)IBA
04/2018
-
10/2016 |
3 | EnzymesIBA
04/2015
-
01/2012 |
3 | ethyl pyruvateIBA
08/2014
-
01/2012 |
3 | Cisplatin (Platino)FDA LinkGeneric
01/2006
-
02/2001 |
3 | Doxorubicin (Adriamycin)FDA LinkGeneric
01/2006
-
01/2000 |
2 | Antineoplastic Agents (Antineoplastics)IBA
03/2021
-
10/2016 |
2 | cycloplatamIBA
10/2016
-
08/2014 |
2 | Proteasome Endopeptidase Complex (Proteasome)IBA
11/2014
-
03/2008 |
2 | Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
08/2014
-
01/2012 |
2 | AmidesIBA
03/2013
-
07/2006 |
2 | AntioxidantsIBA
12/2010
-
06/2005 |
2 | nitroxylIBA
12/2010
-
02/2007 |
1 | IntegrinsIBA
05/2022 |
1 | PoisonsIBA
10/2021 |
1 | Cytochrome P-450 CYP2B1 (PROD)IBA
10/2021 |
1 | N-acetyltalosaminuronic acid (NAT)IBA
10/2021 |
1 | 9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
10/2021 |
1 | ThiazolesIBA
01/2019 |
1 | 2-aminothiazoleIBA
01/2019 |
1 | Topoisomerase InhibitorsIBA
01/2019 |
1 | Caseins (Casein)FDA Link
04/2018 |
1 | RNA (Ribonucleic Acid)IBA
09/2017 |
1 | Radiation-Protective Agents (Radiation Protectants)IBA
09/2017 |
1 | CholesterolIBA
07/2017 |
1 | Phosphatidylcholines (Phosphatidylcholine)IBA
07/2017 |
1 | PlatinumIBA
07/2017 |
1 | cortifenIBA
10/2016 |
1 | Cytostatic AgentsIBA
10/2016 |
1 | Dactinomycin (Actinomycin)FDA LinkGeneric
10/2016 |
1 | Paclitaxel (Taxol)FDA LinkGeneric
11/2015 |
1 | CarcinogensIBA
04/2015 |
1 | MutagensIBA
04/2015 |
1 | peptide permeaseIBA
11/2014 |
1 | Arginine Vasopressin (Argipressin)IBA
11/2014 |
1 | Diethylnitrosamine (N-Nitrosodiethylamine)IBA
07/2014 |
1 | Anticarcinogenic AgentsIBA
07/2014 |
1 | o-AminoazotolueneIBA
07/2014 |
1 | Drinking WaterIBA
10/2013 |
1 | Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2012 |
1 | Small Interfering RNA (siRNA)IBA
01/2012 |
1 | 1- (5- chloro- 1- ((2,4- dimethoxyphenyl)sulfonyl)- 3- (2- methoxyphenyl)- 2- oxo- 2,3- dihydro- 1H- indol- 3- yl)- 4- hydroxy- N,N- dimethyl- 2- pyrrolidinecarboxamideIBA
09/2011 |
1 | Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
09/2011 |
1 | TEMPOIBA
12/2010 |
1 | Pancreatic Ribonuclease (Ribonuclease A)IBA
04/2010 |
1 | Deoxyribonuclease I (Nickase)IBA
04/2010 |
1 | Histocompatibility Antigens Class IIBA
01/2010 |
1 | VaccinesIBA
09/2009 |
1 | Diazepam (Valium)FDA LinkGeneric
03/2009 |
1 | Anti-Anxiety Agents (Anxiolytics)IBA
03/2009 |
1 | Protamines (Protamine Sulfate)FDA Link
01/2009 |
1 | Ethanol (Ethyl Alcohol)IBA
01/2009 |
1 | GD3 ganglioside (GD(3))IBA
02/2007 |
1 | gadodiamide (Omniscan)FDA Link
02/2007 |
1 | EstersIBA
07/2006 |
1 | beta-AlanineIBA
07/2006 |
1 | Amino AcidsFDA Link
07/2006 |
1 | Alanine (L-Alanine)FDA Link
07/2006 |
1 | betulonic acidIBA
07/2006 |
1 | propionic acid (potassium propionate)IBA
07/2006 |
1 | BuffersIBA
06/2005 |
1 | Phenobarbital (Luminal)FDA Link
03/2003 |
1 | Lymphotoxin-alpha (Lymphotoxin)IBA
02/2001 |
1 | Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
01/2000 |
1 | Prednisolone (Predate)FDA LinkGeneric
01/2000 |